Sara van den Berg

84 Chapter 3 Supplementary Figure 5. Pre-vaccination geometric mean titer (pre-GMT) and post-vaccination geometric mean titer (post-GMT) in CMV-seropositive versus CMV-seronegative participants. * Data for Turnet er al was not reported for CMV-seropositivity (n=48), but for different CMV-seropositive groups based on height of anti-CMV IgG level. Here, CMV-seropositive high individuals are shown (subgroup of n=48).